Suppr超能文献

基于离子阱质谱仪的基质辅助激光解吸电离成像质谱法(IMS)在生物组织中药物和代谢物分析中的应用。

Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues.

作者信息

Drexler Dieter M, Garrett Timothy J, Cantone Joseph L, Diters Richard W, Mitroka James G, Prieto Conaway Maria C, Adams Stephen P, Yost Richard A, Sanders Mark

机构信息

Pharmaceutical Candidate Optimization-Discovery Analytical Sciences, 5 Research Parkway, Wallingford, CT 06492, USA.

出版信息

J Pharmacol Toxicol Methods. 2007 May-Jun;55(3):279-88. doi: 10.1016/j.vascn.2006.11.004. Epub 2006 Dec 5.

Abstract

INTRODUCTION

The properties and potential liabilities of drug candidate are investigated in detailed ADME assays and in toxicity studies, where findings are placed in context of exposure to dosed drug and metabolites. The complex nature of biological samples may necessitate work-up procedures prior to high performance liquid chromatography-mass spectrometric (HPLC-MS) analysis of endogenous or xenobiotic compounds. This concept can readily be applied to biological fluids such as blood or urine, but in localized samples such as organs and tissues potentially important spatial, thus anatomical, information is lost during sample preparation as the result of homogenization and extraction procedures. However, the localization of test article or spatial identification of metabolites may be critical to the understanding of the mechanism of target-organ toxicity and its relevance to clinical safety.

METHODS

Tissue imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) and ion trap mass spectrometry (MS) with higher order mass spectrometric scanning functions was utilized for localization of dosed drug or metabolite in tissue. Laser capture microscopy (LCM) was used to obtain related samples from tissue for analyses by standard MALDI-MS and HPLC-MS.

RESULTS

In a toxicology study, rats were administered with a high dosage of a prodrug for 2 weeks. Birefringent microcrystalline material (10-25 microm) was observed in histopathologic formalin-fixed tissue samples. Direct analysis by IMS provided the identity of material in the microcrystals as circulating active drug while maintaining spatial orientation. Complementary data from visual cross-polarized light microscopy as well as standard MALDI-MS and HPLC-MS experiments on LCM samples validated the qualitative results obtained by IMS. Furthermore, the HPLC-MS analysis on the LCM samples afforded a semi-quantitative assessment of the crystalline material in the tissue samples.

DISCUSSION

IMS by MALDI ion trap MS proved sensitive, specific, and highly amenable to the image analysis of traditional small molecule drug candidates directly in tissue.

摘要

引言

在详细的药物吸收、分布、代谢和排泄(ADME)试验以及毒性研究中,会对候选药物的性质和潜在风险进行研究,研究结果会结合给药药物和代谢物的暴露情况进行分析。生物样品的复杂性质可能需要在对内源性或外源性化合物进行高效液相色谱-质谱联用(HPLC-MS)分析之前进行预处理。这一概念很容易应用于血液或尿液等生物流体,但在器官和组织等局部样品中,由于匀浆和提取过程,潜在重要的空间信息(即解剖学信息)在样品制备过程中会丢失。然而,受试物的定位或代谢物的空间鉴定对于理解靶器官毒性机制及其与临床安全性的相关性可能至关重要。

方法

采用基质辅助激光解吸电离(MALDI)和具有高阶质谱扫描功能的离子阱质谱(MS)的组织成像质谱(IMS)技术,对组织中给药药物或代谢物进行定位。激光捕获显微切割(LCM)用于从组织中获取相关样品,以便通过标准MALDI-MS和HPLC-MS进行分析。

结果

在一项毒理学研究中,给大鼠高剂量施用一种前药,持续2周。在组织病理学福尔马林固定的组织样品中观察到双折射微晶材料(10 - 25微米)。通过IMS直接分析确定微晶中的物质为循环活性药物,同时保持空间方向。来自视觉交叉偏振光显微镜以及LCM样品的标准MALDI-MS和HPLC-MS实验的补充数据验证了IMS获得的定性结果。此外,对LCM样品的HPLC-MS分析对组织样品中的结晶物质进行了半定量评估。

讨论

MALDI离子阱MS的IMS技术被证明对直接在组织中成像分析传统小分子候选药物具有灵敏性、特异性和高度适用性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验